DNASTAR and the Oklahoma Medical Research Foundation sign Software Site License Agreement

5 May 2008

DNASTAR, a leading bioinformatics software company, and the Oklahoma Medical Research Foundation (OMRF) announced today the signing of a broad site license agreement for the use of Lasergene® sequence analysis software developed by DNASTAR.

Under the terms of the site license, Lasergene will be available to an unlimited number of users at the Foundation, which is located in Oklahoma City, OK, for a 4 year time period. Founded in 1946, OMRF is one of the oldest and most respected non-profit medical research centers in the USA, focusing much of its efforts in the search for the causes and cures for heart disease, Alzheimer’s and other brain diseases, cancer and diabetes. Lasergene is comprehensive sequence analysis software that provides users with tools for performing a wide range of assembly, visualization and analysis operations on data generated by conventional Sanger sequencing method as well as Next Generation techniques. The desktop software allows users to analyze samples ranging from small plasmids up to large bacterial genomes. Tools such as Lasergene provide scientists with invaluable information on the molecular issues associated with genetic disorders.

Bob Steinhauser, DNASTAR’s Director of Marketing, “DNASTAR is very pleased that the Oklahoma Medical Research Foundation has selected Lasergene to be used by a broad number of its scientists... This continues the strong trend seen from large medical research facilities to provide software to entire research staff to enhance research cooperation. As the field of sequence analysis continues to changes rapidly, our approach to providing molecular biologists with constant technical upgrades as they become available, assures them of having the most advanced software tools available for their research requirements.. Lasergene’s features make it an excellent platform to base their future genomic research needs.”

Lasergene is a comprehensive, easy to use suite of tools for molecular biologists and geneticists used primarily in the assembly and analysis of DNA and protein sequences. The software provides researchers with a broad range of analysis tools that can be used with traditional and Next-Generation sequence analysis projects. It has been sold in over 65 countries worldwide and the Oklahoma Medical Research Foundation joins a growing list of public and private organizations that are utilizing the Lasergene sequence analysis software program.

Links

Tags